Yoshio Yamaoka Selected Research

Salts

9/2018	Pathogenesis of Helicobacter pylori infection.
8/2018	New observations regarding Helicobacter pylori and gastric cancer in Mongolia.
1/2018	The prevalence of Helicobacter pylori infection and other risk factors among Mongolian dyspeptic patients who have a high incidence and mortality rate of gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshio Yamaoka Research Topics

Disease

99	Infections 01/2024 - 01/2002
49	Stomach Neoplasms (Stomach Cancer) 07/2023 - 09/2002
34	Neoplasms (Cancer) 01/2023 - 01/2002
25	Inflammation (Inflammations) 01/2023 - 08/2002
14	Gastritis 09/2022 - 06/2002
12	Duodenal Ulcer (Curling's Ulcer) 07/2023 - 01/2002
12	Hepatocellular Carcinoma (Hepatoma) 09/2006 - 03/2002
11	Atrophy 01/2022 - 08/2002
9	Fibrosis (Cirrhosis) 01/2010 - 04/2002
8	Metaplasia 01/2023 - 08/2002
8	Peptic Ulcer (Peptic Ulcers) 01/2018 - 01/2002
7	Atrophic Gastritis 09/2023 - 03/2010
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2010 - 04/2002
6	Ischemia 12/2006 - 02/2002
6	Neoplasm Metastasis (Metastasis) 08/2004 - 01/2002
5	Reperfusion Injury 01/2014 - 04/2003
4	Stomach Diseases 11/2023 - 03/2016
4	Persistent Infection 03/2022 - 10/2014
4	Carcinoma (Carcinomatosis) 12/2016 - 01/2008
4	Carcinogenesis 03/2012 - 12/2002
4	Hepatitis 01/2005 - 05/2002
3	Chronic Hepatitis (Chronic Active Hepatitis) 09/2006 - 02/2002
3	Ulcer 04/2005 - 01/2002
2	Necrosis 11/2023 - 08/2004
2	Dyspepsia (Indigestion) 01/2023 - 04/2019
2	Colitis 01/2023 - 02/2019
2	Adenocarcinoma 01/2023 - 02/2014
2	COVID-19 12/2022 - 08/2022
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2022 - 01/2016
2	Hemorrhage 01/2022 - 01/2002
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2017 - 12/2002
2	Bacterial Infections (Bacterial Infection) 01/2017 - 01/2008
2	Stomach Ulcer (Gastric Ulcer) 01/2015 - 11/2003
2	Communicable Diseases (Infectious Diseases) 08/2007 - 01/2005
2	Liver Neoplasms (Liver Cancer) 09/2006 - 01/2002
2	Liver Diseases (Liver Disease) 09/2006 - 08/2004

Drug/Important Bio-Agent (IBA)

26	Virulence Factors (Pathogenicity Factors)IBA 01/2022 - 06/2002
19	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2002
18	Interleukin-8 (Interleukin 8)IBA 01/2023 - 08/2002
14	Messenger RNA (mRNA)IBA 10/2017 - 12/2002
12	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2002
10	CytokinesIBA 02/2023 - 04/2005
9	UreaseIBA 01/2024 - 05/2013
9	Cytotoxins (Cytolysins)IBA 01/2023 - 11/2005
8	AntibodiesIBA 09/2023 - 06/2004
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2002
8	AntralIBA 01/2019 - 04/2005
7	Interleukin-6 (Interleukin 6)IBA 11/2023 - 12/2002
7	Pepsinogen A (Pepsinogen)IBA 09/2023 - 10/2013
7	AntigensIBA 12/2022 - 02/2002
7	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 01/2008
6	alpha-Fetoproteins (alpha-Fetoprotein)IBA 06/2007 - 05/2002
6	Thioacetamide (Thioacetamid)IBA 01/2005 - 02/2003
5	Oncogene Proteins (Oncogene Protein)IBA 07/2023 - 04/2012
5	AcidsIBA 09/2020 - 01/2009
5	InterleukinsIBA 11/2011 - 12/2002
4	Clarithromycin (Biaxin)FDA LinkGeneric 12/2022 - 05/2017
4	Interleukin-17 (Interleukin 17)IBA 01/2021 - 12/2008
4	Blood Group Antigens (Blood Groups)IBA 03/2011 - 12/2004
3	Cadherins (E-Cadherin)IBA 01/2023 - 05/2006
3	16S Ribosomal RNAIBA 09/2022 - 01/2020
3	Metronidazole (Metric)FDA LinkGeneric 01/2022 - 01/2019
3	Immunoglobulin G (IgG)IBA 07/2021 - 01/2017
3	Cytochrome P-450 CYP2C19IBA 04/2021 - 01/2015
3	Levofloxacin (Levaquin)FDA Link 01/2019 - 03/2016
3	SaltsIBA 09/2018 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009 - 08/2004
3	Interleukin-18 (Interleukin 18)IBA 11/2009 - 01/2008
3	ThioredoxinsIBA 01/2005 - 05/2003
3	Ethanol (Ethyl Alcohol)IBA 12/2004 - 01/2002
3	Complementary DNA (cDNA)IBA 01/2004 - 12/2002
3	Indicators and Reagents (Reagents)IBA 02/2002 - 01/2002
2	LatexIBA 09/2023 - 08/2021
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2023 - 08/2022
2	BismuthIBA 01/2023 - 01/2019
2	Small Interfering RNA (siRNA)IBA 11/2021 - 12/2016
2	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2021 - 06/2008
2	PepsinogensIBA 01/2020 - 01/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 12/2002
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 04/2018 - 01/2017
2	Proton Pump InhibitorsIBA 01/2018 - 01/2009
2	PhosphotyrosineIBA 01/2016 - 01/2014
2	Interleukin-10 (Interleukin 10)IBA 01/2015 - 01/2015
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014 - 11/2003
2	Phosphotransferases (Kinase)IBA 06/2012 - 01/2009
2	Angiotensin IIIBA 03/2012 - 12/2004
2	Transcription Factors (Transcription Factor)IBA 01/2008 - 03/2007
2	NF-kappa B (NF-kB)IBA 03/2007 - 03/2005
2	ElementsIBA 03/2007 - 04/2004
2	InterferonsIBA 03/2007 - 04/2004
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 05/2006 - 02/2003
2	Interleukin-1 (Interleukin 1)IBA 12/2004 - 12/2002

Therapy/Procedure

22	Therapeutics 11/2023 - 01/2002
5	Palliative Care (Palliative Therapy) 12/2015 - 08/2008
4	Warm Ischemia 01/2014 - 02/2002
3	Hepatectomy 04/2005 - 05/2002
2	Drug Therapy (Chemotherapy) 01/2024 - 02/2014
2	Renal Dialysis (Hemodialysis) 02/2011 - 01/2009
2	Transplantation 09/2005 - 08/2005
2	Liver Transplantation 09/2005 - 03/2002